G
GENI
vs
F
FTSE All Share Index
Over the past 12 months, GENI has outperformed FTSE All Share Index, delivering a return of -56% compared to the FTSE All Share Index's 0% growth.
Stocks Performance
GENI vs FTSE All Share Index
Performance Gap
GENI vs FTSE All Share Index
Performance By Year
GENI vs FTSE All Share Index
Compare the stock's returns with its benchmark index and competitors. Gain insights into its relative performance over time.
Genincode PLC
Glance View
GENinCode UK Ltd. engages in the risk assessment and prediction of cardiovascular disease. The company is headquartered in Oxford, Oxfordshire. The company went IPO on 2021-07-22. The firm develops patented deoxyribonucleic acid (DNA) risk assessment products which utilize artificial intelligence (AI), bioinformatics and a globally recognized clinical evidence base to provide predictive analysis of a patient’s health risk. The Company’s clinical diagnostic tests cover global disease areas such as cardiovascular, cancer and diabetes.